New York State Common Retirement Fund’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-74,700
| Closed | -$1.41M | – | 3254 |
|
|
2019
Q3 | $1.41M | Hold |
74,700
| – | – | ﹤0.01% | 1817 |
|
|
2019
Q2 | $879K | Buy |
74,700
+20,100
| +37% | +$243K | ﹤0.01% | 2087 |
|
|
2019
Q1 | $745K | Sell |
54,600
-5,900
| -10% | -$76.4K | ﹤0.01% | 2110 |
|
|
2018
Q4 | $620K | Sell |
60,500
-7,600
| -11% | -$97.3K | ﹤0.01% | 2178 |
|
|
2018
Q3 | $1.13M | Buy |
68,100
+5,500
| +9% | +$99.4K | ﹤0.01% | 2021 |
|
|
2018
Q2 | $989K | Sell |
62,600
-5,800
| -8% | -$88.1K | ﹤0.01% | 2103 |
|
|
2018
Q1 | $869K | Buy |
68,400
+4,600
| +7% | +$66.5K | ﹤0.01% | 2105 |
|
|
2017
Q4 | $731K | Buy |
63,800
+12,800
| +25% | +$143K | ﹤0.01% | 2195 |
|
|
2017
Q3 | $625K | Hold |
51,000
| – | – | ﹤0.01% | 2256 |
|
|
2017
Q2 | $584K | Sell |
51,000
-1
| -0% | -$18 | ﹤0.01% | 2337 |
|
|
2017
Q1 | $1.06M | Buy |
51,001
+1
| +0% | +$22 | ﹤0.01% | 1996 |
|
|
2016
Q4 | $1.06M | Sell |
51,000
-4,235
| -8% | -$110K | ﹤0.01% | 2008 |
|
|
2016
Q3 | $1.81M | Buy |
55,235
+7,235
| +15% | +$220K | ﹤0.01% | 1708 |
|
|
2016
Q2 | $1.2M | Buy |
48,000
+23,900
| +99% | +$647K | ﹤0.01% | 1878 |
|
|
2016
Q1 | $590K | Sell |
24,100
-3,824
| -14% | -$88.5K | ﹤0.01% | 2183 |
|
|
2015
Q4 | $922K | Buy |
27,924
+3,928
| +16% | +$133K | ﹤0.01% | 2030 |
|
|
2015
Q3 | $786K | Buy |
23,996
+3,001
| +14% | +$128K | ﹤0.01% | 2089 |
|
|
2015
Q2 | $1.11M | Buy |
20,995
+17,594
| +517% | +$640K | ﹤0.01% | 2119 |
|
|
2015
Q1 | $98K | Buy |
+3,401
| New | +$93.3K | ﹤0.01% | 2222 |
|
New York State Common Retirement Fund's ALDR Position: Q4 2019 in Review
New York State Common Retirement Fund sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 74,700 shares — an estimated $1.41M sold.
New York State Common Retirement Fund first reported a position in ALDR in Q1 2015 and held it in 19 quarters. The position peaked at $1.81M in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- New York State Common Retirement Fund reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- New York State Common Retirement Fund sold 74,700 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.41M.
- New York State Common Retirement Fund first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 19 quarters.
- New York State Common Retirement Fund's Alder Biopharmaceuticals position peaked at $1.81M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on New York State Common Retirement Fund's 13F filing for Q4 2019, filed 5 Feb 2020.